INCYTE (INCY) Covered Calls

INCYTE covered calls Incyte Corporation is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

You can sell covered calls on INCYTE to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for INCY (prices last updated Mon 4:16 PM ET):

INCYTE (INCY) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
69.05 +0.25 65.00 73.25 1.4M - 15B
Covered Calls For INCYTE (INCY)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 70 2.30 70.95 -1.3% -14.4%
Oct 19 70 3.40 69.85 0.2% 1.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Incyte Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of proprietary small molecule drugs to treat serious unmet medical needs. The company's product, Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers. Incyte was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.